Home | About IJMPO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Indian Journal of Medical and Paediatric Oncology
Search Article 
Advanced search 
Year : 1995  |  Volume : 16  |  Issue : 1  |  Page : 36-38

Hydroxyurea in early blastic transformation of chronic myeloid leukemia.

Dept of Medicine, King George's Medical College, Lucknow, India

Correspondence Address:
H Agarwal
Dept of Medicine, King George's Medical College, Lucknow, India

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

We report the role of hydroxyurea in tow patients of chronic myeloid leukemia in early stages of blastic transformation. Both these patients had presented in chronic phase. They attained remission by hydroxyurea and were subsequently maintained in this phase by hydroxyurea 2gm biweekly. On development of bastic transformation hydroxyurea 2gm/day ws instituted along with supportive treatment. No conventional chemotherapy was given. There was significant reduction in number of blast cells, total leucocyte counts, platelets counts with significant symptomatic relief for six to eight months.

[PDF Not available]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal